Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation - Enkhbaatar, P; Okajima, K; Murakami, K (Am J Respir Crit Care Med, 2000)
et al.